DiagnaMed Holdings Corp. engages in providing artificial intelligence (AI) healthcare solutions. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-11-08. The firm delivers technology solutions for the cleantech and life sciences industries, with a focus on hydrogen production and artificial intelligence (AI)-driven drug discovery and diagnostics. The firm is focused on the commercialization of two technologies, such as a proprietary electromagnetic heating technology enabling hydrogen production from petroleum reservoirs and natural hydrogen fields, and BRAIN AGE BRAIN HEALTH, a proprietary brain health AI platform for the healthcare market. Its Brain Tremor is an investigating technological application that monitors, collects and uses individual information to detect tremors, and measure cognitive and brain activity in patients with neurological disorders. BRAIN AGE Brain Health is a brain health AI platform that aims to predict and monitor brain age and provide actionable insights into mental health and neurodegenerative disorders.
Follow-Up Questions
¿Quién es el CEO de DiagnaMed Holdings Corp?
Mr. Fabio Chianelli es el Chairman of the Board de DiagnaMed Holdings Corp, se unió a la empresa desde 2021.
¿Qué tal es el rendimiento del precio de la acción DGNMF?
El precio actual de DGNMF es de $0.066, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de DiagnaMed Holdings Corp?
DiagnaMed Holdings Corp pertenece a la industria N/A y el sector es N/A
¿Cuál es la capitalización bursátil de DiagnaMed Holdings Corp?
La capitalización bursátil actual de DiagnaMed Holdings Corp es $7.2M
